Usd · CUSIP G50871105 · who reports it, how much, and how much it matters to them
31 of the 720 hedge fund managers we track reported shares of Jazz Pharmaceuticals plc (Nasdaq: JAZZ) on Form 13F for 30 June 2026. Between them they reported USD 1.1bn. The largest position belongs to Citadel Advisors, at USD 243m. The manager with the most riding on it is GMT Capital, where it is 5.7% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Citadel Advisors32 funds on PPLI.com | USD 243m | 0.0% |
| 2 | Millennium Management6 funds on PPLI.com | USD 184m | 0.1% |
| 3 | Renaissance Technologies13 funds on PPLI.com | USD 135m | 0.2% |
| 4 | GMT Capital3 funds on PPLI.com | USD 109m | 5.7% |
| 5 | Two Sigma Investments35 funds on PPLI.com | USD 96m | 0.1% |
| 6 | Sofinnova Investments1 fund on PPLI.com | USD 88m | 4.6% |
| 7 | GoldenTree Asset Management31 funds on PPLI.com | USD 71m | 4.1% |
| 8 | Perceptive Advisors6 funds on PPLI.com | USD 41m | 0.6% |
| 9 | Holocene Advisors2 funds on PPLI.com | USD 39m | 0.1% |
| 10 | PFM Health Sciences3 funds on PPLI.com | USD 39m | 3.3% |
| 11 | D. E. Shaw & Co.15 funds on PPLI.com | USD 21m | 0.0% |
| 12 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 19m | 0.1% |
| 13 | Exoduspoint Capital Management7 funds on PPLI.com | USD 13m | 0.1% |
| 14 | Squarepoint Ops7 funds on PPLI.com | USD 13m | 0.0% |
| 15 | Marshall Wace LLP84 funds on PPLI.com | USD 8.4m | 0.0% |
| 16 | Ardsley Advisory Partners6 funds on PPLI.com | USD 7.2m | 0.8% |
| 17 | Cercano Management5 funds on PPLI.com | USD 4.2m | 0.6% |
| 18 | Lighthouse Investment Partners190 funds on PPLI.com | USD 3.6m | 0.1% |
| 19 | Atom Investors1 fund on PPLI.com | USD 3.2m | 0.3% |
| 20 | Weiss Asset Management5 funds on PPLI.com | USD 2.9m | 0.0% |
| 21 | Castleknight Management3 funds on PPLI.com | USD 2.9m | 0.0% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 1.5m | 0.0% |
| 23 | Capricorn Fund Managers8 funds on PPLI.com | USD 1.5m | 0.1% |
| 24 | Fora Capital1 fund on PPLI.com | USD 1.3m | 0.1% |
| 25 | Wolverine Asset Management1 fund on PPLI.com | USD 561,000 | 0.0% |
| 26 | Balyasny Asset Management25 funds on PPLI.com | USD 487,000 | 0.0% |
| 27 | CIBC Asset Management69 funds on PPLI.com | USD 459,000 | 0.0% |
| 28 | Aquatic Capital Management3 funds on PPLI.com | USD 456,000 | 0.0% |
| 29 | BTG Pactual Asset Management US11 funds on PPLI.com | USD 350,000 | 0.0% |
| 30 | Persistent Asset Partners10 funds on PPLI.com | USD 280,000 | 0.1% |
| 31 | The Quarry1 fund on PPLI.com | USD 2,169 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | GMT Capital | USD 109m | 5.7% |
| 2 | Sofinnova Investments | USD 88m | 4.6% |
| 3 | GoldenTree Asset Management | USD 71m | 4.1% |
| 4 | PFM Health Sciences | USD 39m | 3.3% |
| 5 | Ardsley Advisory Partners | USD 7.2m | 0.8% |
| 6 | Perceptive Advisors | USD 41m | 0.6% |
| 7 | Cercano Management | USD 4.2m | 0.6% |
| 8 | Atom Investors | USD 3.2m | 0.3% |
| 9 | Renaissance Technologies | USD 135m | 0.2% |
| 10 | Capricorn Fund Managers | USD 1.5m | 0.1% |
Jazz Pharmaceuticals plc trades under the symbol JAZZ on the Nasdaq. Its CUSIP, the code used on Form 13F, is G50871105.
31 of the 720 hedge fund managers PPLI.com tracks reported Jazz Pharmaceuticals plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 243m), Millennium Management (USD 184m), Renaissance Technologies (USD 135m), GMT Capital (USD 109m) and Two Sigma Investments (USD 96m).
31 managers in our coverage reported it, and between them they run 615 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
GMT Capital, where the position was 5.7% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Jazz Pharmaceuticals plc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.